• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant

SandboxAQ and Google Cloud Partner to Optimize Large Quantitative Models

by Jasmine Pennic 01/21/2025 Leave a Comment

SandboxAQ and Google Cloud Partner to Optimize Large Quantitative Models

What You Should Know:  - SandboxAQ, a leader in artificial intelligence (AI) solutions, today announced a strategic partnership with Google Cloud to integrate and optimize its platform of Large Quantitative Models (LQMs) on Google Cloud.  - The collaboration will leverage Google Cloud's robust infrastructure and advanced capabilities to enhance the performance and scalability of SandboxAQ's AI solutions while making them more accessible to customers through Google Cloud
Read More

Mayo Clinic, SandboxAQ Expand Collaboration to Advance AI Cardiac Diagnostics in Amyloidosis

by Fred Pennic 01/17/2025 Leave a Comment

Mayo Clinic, SandboxAQ Expand Collaboration to Advance AI Cardiac Diagnostics

What You Should Know: - Mayo Clinic is expanding its collaboration with SandboxAQ, a provider of artificial intelligence (AI) medical apps to explore the use of electrocardiography (ECG) and magnetocardiography (MCG) technologies for characterizing disease progression and treatment response in patients with amyloidosis. - The expanded partnership highlights the potential of combining AI and advanced sensing technology to revolutionize cardiac diagnostics. Improved Detection and
Read More

Century Health to Curate Real World EHR Data for MS Research and Treatments

by Fred Pennic 01/17/2025 Leave a Comment

Century Health to Curate Real World EHR Data for MS Research and Treatments

What You Should Know:  - Century Health, a provider in applying artificial intelligence (AI) to real-world data for research acceleration, and Nira Medical, a national leader in neurological care delivery, announced a strategic partnership to advance the understanding of multiple sclerosis (MS) and improve patient outcomes. - The collaboration will leverage Century Health's AI platform to curate and structure data from over 3,000 MS patients treated within Nira Medical's network of
Read More

Proprio and LifeHealthcare Expand AI Surgical Guidance in Southeast Asia

by Syed Hamza Sohail 01/17/2025 Leave a Comment

Proprio and LifeHealthcare Expand AI Surgical Guidance in Southeast Asia

What You Should Know: - Proprio, the global leader in AI-powered surgical technology, today announced a strategic partnership with LifeHealthcare, a subsidiary of EBOS Group Limited. Through this partnership, LifeHealthcare will serve as the distribution partner of Proprio Paradigm in Australia and New Zealand.  -  Additional phases of the agreement will expand distribution of the AI surgical guidance system throughout Southeast Asia. Addressing Global Surgical Challenges with Proprio's
Read More

Diaceutics and Cornerstone AI Partner to Enhance Lab Data for Precision Medicine

by Syed Hamza Sohail 01/17/2025 Leave a Comment

Diaceutics and Cornerstone AI Partner to Enhance Lab Data for Precision Medicine

What You Should Know: -  Diaceutics, a leading technology and solutions provider to the life science industry, and Cornerstone AI, a leading AI-based data quality and data enhancement platform, today announced a strategic partnership to enhance the accuracy, completeness, and usability of data from the DXRX laboratory network.  -  The collaboration integrates Cornerstone AI’s proprietary lab data algorithms with Diaceutics’ real-world data ecosystem, generating LOINC assignments to deliver
Read More

25 Executive Healthcare AI Predictions & Trends to Watch in 2025

by Fred Pennic 01/16/2025 Leave a Comment

24 Executive Healthcare AI Predictions & Trends to Watch in 2025

From AI-powered diagnostics to personalized medicine, we asked twenty four healthcare executives their insights on trends and technologies that will transform patient care in the coming year. Ashley Barrow, Founder and CEO of RE-Assist In 2025, Artificial Intelligence and the T.E.A.M. (Transforming Episode-Based Accountable Management) model will redefine care coordination, creating a smarter, faster, and more equitable healthcare system. Primary care will evolve to include more
Read More

The Digital Doctor Is In: How AI Self-Triage Redefines Virtual Care

by Dr. Jakub Jaszczak, Sr. Product Manager, Infermedica 01/16/2025 Leave a Comment

Imagine a world where your smartphone becomes your first line of defense against illness – where artificial intelligence (AI) can assess symptoms, offer personalized advice, and guide you to the right care faster than ever before. This isn’t science fiction; it’s the rapidly emerging reality of AI-powered self-triage in healthcare. As patient needs grow more complex and healthcare systems strain under increasing demand, these innovative tools are poised to revolutionize how we access and
Read More

Is AI Failing Drug Development? The Unseen Challenges

by Noam Solomon, CEO at Immunai 01/16/2025 Leave a Comment

Is AI Failing Drug Development? The Unseen Challenges

For over a decade, we've heard about AI's transformative potential in therapeutics (Tx), but where's the evidence? Has it all been hype? Can AI still revolutionize Tx? Or is there something the AI experts aren't telling us? First, some facts. The process of Tx development—from early clinical trials to FDA approval—is excruciatingly slow (over 10 years), expensive (over $2B, especially for immunotherapy drugs), and comes with a low probability of success (5% in Immune-Oncology, and similarly
Read More

Overprescribing and Polypharmacy: Arine CEO Talks The Hidden Dangers of Amazon’s Same-Day Prescription Delivery

by Fred Pennic 01/15/2025 Leave a Comment

As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high. In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may inadvertently contribute to dangerous polypharmacy and medication mismanagement. She comments on the critical challenges facing healthcare providers, from fragmented medication tracking to rapidly evolving drug knowledge, and explores how AI-powered solutions can help ensure safe, effective medication management in an increasingly automated healthcare landscape. What are the potential benefits and risks of ultra-fast prescription delivery services like Amazon Pharmacy's same-day delivery? How can these services impact patient access to medications and adherence to treatment plans? Yoona Kim, Founder & CEO at Arine: Ultra-fast prescription delivery services like Amazon Pharmacy’s same-day delivery offer clear benefits to patients, particularly those with acute health needs. Instead of having to pick up medication from the pharmacy – while potentially feeling under the weather – patients can have medications delivered straight to their door within hours. It’s easy to see why this level of convenience is appealing, especially as we grow accustomed to rapid delivery in other areas of our lives, such as grocery shopping. However, this convenience comes with considerable risks in our already fragmented healthcare ecosystem. To start, it complicates providers’ ability to track a patient’s medications. People often, and erroneously, assume that healthcare providers have a clear, comprehensive picture of a patient’s prescriptions, but that’s not usually the case. For example, when someone is admitted to the hospital, their doctors need to piece together their medication history, often by conducting a medication review with the patient, calling their PCP, consulting specialists, and sometimes reaching out to family members. Even with those efforts, up to two-thirds of hospital patients have something missing or incorrect in their medication records, which can lead to risky drug interactions. In addition, patients are often confused by their medications. For these individuals, having an additional interaction with a pharmacist can be invaluable. As medication therapies become more complex, the role of pharmacists has expanded beyond simply dispensing, to educating patients around safe medication use, and warning them about drug interactions. When this touchpoint is removed, patients may lose an opportunity for crucial medication counseling. So while Amazon’s prescription delivery might be a game-changer when it comes to convenience and speed, we do need to ensure that it isn’t hindering providers’ ability to quickly access accurate medication information, and not preventing patients’ access to comprehensive medication counseling. Could these services' convenience and speed inadvertently contribute to overprescribing and polypharmacy? If so, how? Yoona Kim: While the convenience and speed of same-day delivery are a huge win for patients, it’s important to remember that medication isn’t the same as groceries or other deliveries – even the most common and seemingly harmless drugs need careful consideration from healthcare professionals. When big retailers start handling medications like they do other consumer products, it can unintentionally reduce the medication oversight patients really need. It is already difficult enough for providers to weigh the risks and benefits of medications with existing data silos. At the same time, pharmacists do not have sufficient visibility into medications dispensed at other pharmacies to catch potential interactions. The shift toward a fast, Amazon Prime-style delivery model could make this situation even more difficult, since it's adding yet another dispensing pharmacy into the mix. We really need safeguards to make sure patients aren’t getting medications they don’t need – or worse, medications that could harm them. One of the big risks here is inappropriate polypharmacy, which happens when patients end up taking five or more medications at once. Today, about 1 in 5 adults take five or more medications; with the rate twice as much for older adults. This is a serious issue that can lead to dangerous drug interactions which put patients at risk of hospitalization and even death. When patients can conveniently refill their prescriptions and have them delivered in just a few clicks, medications can arrive without a clinician reassessing whether they’re still right for the patient. As a result, a patient could receive a drug they no longer need or even a duplicate prescription. It’s not the convenience that’s the problem, but we do need safeguards. If we don’t address this, we could see over 4.6 million additional hospitalizations and as many as 150,000 premature deaths in the US over the next decade alone. What are the potential consequences of overprescribing and polypharmacy for patients, including adverse drug interactions, increased hospitalizations, and higher healthcare costs? Yoona Kim: The risks of overprescribing and polypharmacy are well-documented and, unfortunately, very real for patients – the more drugs you’re on, the higher the chances of costly and harmful drug interactions and other consequences. Take elderly patients with heart disease – when they're on five or more medications, their healthcare costs nearly double while their pharmacy expenses triple compared to those taking fewer drugs. Patients taking five or more medications face nearly twice the risk of adverse drug events, leading to outpatient clinic or emergency room visits. This trend is especially concerning in certain disease areas such as behavioral health where we're seeing an alarming increase in polypharmacy. Currently 60% of adults with behavioral health conditions are prescribed two or more psychotropic medications, a practice that frequently leads to more emergency room visits and higher healthcare costs. Hyperpolypharmacy – when a patient is on 10 or more medications – can be even more consequential. A study found that hyperpolypharmacy remained significantly associated with an increased risk for hospitalization for any reason and any serious adverse event. Despite these risks, polypharmacy has been rising quickly. In the past two decades, the number of older adults in the US taking five or more medications has almost doubled to over 44%. Addressing polypharmacy can be tricky and there is no known structured approach given that these are patient-specific interventions with many factors to consider such as patient goals, medications used, and preferences. There are treatment guidelines for initiating treatment for almost every disease area, but not as clear in these guidelines is when to discontinue medications. Regular reviews of each patient’s medications are essential so clinicians can spot duplicates and identify any drugs that may be causing more harm than good. This way, when necessary and possible, they can work with patients on a safe plan to deprescribe – in other words, taper off these medications. But achieving that level of oversight becomes harder as the focus on convenience and rapid refills continues to grow. How does the rapid evolution of medication knowledge and drug interactions challenge healthcare providers to ensure safe and effective medication management? Yoona Kim: Medication knowledge is evolving faster than ever, which can actually be a double-edged sword for healthcare providers. Every year, dozens of new drugs get FDA approval, while existing medications gain new uses – or new warnings about potential risks. Doctors are trained on medications during medical school, but keeping up with all the updates year after year is almost impossible. This constant influx of new drugs and changing guidelines means that even the best-resourced healthcare providers can struggle to stay fully informed. There are platforms that providers can use to look up drug interactions and active ingredients, but these resources don’t account for all the individual factors that might impact how someone responds to a medication. For truly safe and effective medication management, providers need a full, up-to-date view of not only the drugs themselves but also the patient’s unique clinical, social and behavioral circumstances. Keeping track of all this information in real time is a major challenge for healthcare providers, especially as medication knowledge continues to expand. What are the potential consequences of medication mismanagement across the healthcare continuum, from primary care to hospitals and long-term care facilities? Yoona Kim: The consequences of medication mismanagement are severe across the continuum. In fact, medication-related problems are the largest area of waste in our healthcare system and 1 in every 6 healthcare dollars or $528B annually are spent on consequences from suboptimal medications. To illustrate this issue, let me share the story of two patients we’ve encountered at Arine. Patient E, a man with heart failure, diabetes, COPD, and previous hospitalizations was prescribed multiple doses of the same heart medications by different providers over two months. Every time he was hospitalized again or received a new prescription, he didn’t understand that he was supposed to stop taking the previous medication he’d been prescribed. No one noticed that he was taking multiple duplicates of 6 heart failure medications at the same time, which could have led to renal failure and cardiac arrest. Without intervention, the outcome could have been fatal. Patient P who was battling multiple heart conditions – including heart failure, atrial fibrillation, and a previous heart attack, alongside COPD and blood clotting issues – had experienced multiple hospitalizations within a year. Despite the severity of his conditions, he struggled with taking his prescribed heart and blood-thinning medications consistently and had gone nearly a year without seeing a cardiologist. He was also missing key medications necessary to better manage his condition. Without proper medication adherence, additional necessary treatments, and specialist oversight, his health was at significant risk for further decline and complications. These are just two examples, but millions of Americans face similar challenges every day. There’s a common misconception that doctors and pharmacists have full control over patients’ meds. But in reality, keeping track of everything from a patient’s full medical history to their socioeconomic challenges – like paying for meds, transportation issues or even health literacy barriers – is incredibly hard. Providers would need a complete 360-degree view of each patient’s life to get every prescription right, which is just not realistic with the current system. How can technology and AI be leveraged to enhance medication management and reduce the risks of overprescribing and polypharmacy? Yoona Kim: Using technology and AI is the only way to tackle an issue as enormous as medication management. The complexity of today’s healthcare system and the sheer volume of medication knowledge make it impossible for providers to keep track of every new guideline or patient-specific factor without the support of technology. AI can sift through massive data sets in order to connect the dots between the latest medication information and each patient’s unique health and life circumstances to recommend a safe, optimized medication plan. Can you explain how Arine's medication intelligence platform addresses the challenges of overprescribing and other forms of medication mismanagement? Yoona Kim: Our AI-powered medication intelligence platform assesses everything from optimal drug choice, drug dose, or duplication errors and harmful interactions, to socioeconomic factors that could be acting as a blocker in an otherwise sound treatment plan. These are presented to the provider as specific data-driven recommendations, including contextual information about the patient’s circumstances, and helps them make more informed decisions. In areas like overprescribing, this is essential. Our platform flags unnecessary medications that may be causing more harm than benefit and suggests deprescribing or changing medications as needed, again in the context of the full patient picture. While much of the conversation around AI in healthcare has been purely speculative, Arine’s technology offers a tangible solution to a specific problem with proven positive impacts on patient outcomes. Through medication intelligence, we were able to identify and correct the medication errors that were affecting Patient E and Patient P’s treatment plans. Patient E’s duplicative heart failure medications were deprescribed and his heart failure is much better controlled on fewer medications and lower costs. Patient P was counseled on the importance of adherence and put on a more comprehensive treatment regimen with additional heart failure medications to prevent more hospitalizations, supported by his new cardiologist. What are the key challenges and opportunities that lie ahead in addressing medication mismanagement, particularly as the paradigm of drug dispensing continues to evolve? Yoona Kim: As more retailers like Amazon move into pharmacy, there’s a big shift toward automation, and with it, both challenges and opportunities. One of the biggest concerns is the potential for automated prescription refills to create a disconnect between healthcare providers and patients. Providers need visibility to all dispensed medications and the full patient picture to properly review and prevent unnecessary negative consequences of medication errors. Patients need proper counseling as taking medications incorrectly could end up undoing the convenience that automated services are trying to provide. On the flip side, automation could actually be a major win for healthcare, especially in reducing the heavy administrative workload on doctors and pharmacists. Streamlining some of these repetitive tasks could free up their time for direct patient care, and help to prevent burnout and keep more providers in the profession. But it’s all about balance – if we’re building guardrails to ensure that the convenience at the prescription level flows all the way through to safe, efficient care, particularly leveraging AI and technology, we stand to improve patient outcomes and reduce costs. About Yoona Kim Yoona Kim is the CEO and co-founder of Arine, a next-generation medication intelligence company with a mission to solve medication mismanagement across the healthcare continuum. Arine’s proprietary platform pulls insights from a complex ecosystem of clinical, socioeconomic, and behavioral data to generate personalized care plans and deliver value-based care. Yoona previously led clinical and health economic activities at leading digital health and pharma companies including Novartis and Gilead. She also implemented innovative healthcare design and value-based insurance programs for large self-insured employers at Mercer Health and Benefits. She holds a bachelor’s degree from Stanford University, a PharmD with an emphasis in health policy and management from the University of California, San Francisco, and a PhD in health economics and outcomes from the University of Texas at Austin.

As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high. In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may
Read More

How Clinical Pharmacist-Led Telehealth Models Are Transforming Diabetes Care

by Cynthia Chioma Nwaubani, PharmD, BCGP, CEO and founder, PharmD Live 01/15/2025 Leave a Comment

How Clinical Pharmacist-Led Telehealth Models Are Transforming Diabetes Care

Diabetes, a chronic condition affecting millions of Americans, is on the rise. According to the CDC, 15.8% of the U.S. population now lives with diabetes. With over 38 million people managing this complex disease, effective care is essential. Yet, access to diabetes care has become increasingly challenging, especially for underserved communities. The closure of primary care clinics by major retail pharmacy chains has further strained access to care, leaving vulnerable populations without the
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 27
  • Go to page 28
  • Go to page 29
  • Go to page 30
  • Go to page 31
  • Interim pages omitted …
  • Go to page 219
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |